**Title: Pallimed Solutions, Inc. Initiates Voluntary Recall of Sterile Compound Products Due to Visible Particulates**
**Issue Summary:**
Pallimed Solutions, Inc., operating as Pallimed Pharmacy in Woburn, MA, is voluntarily recalling all sterile compound products dispensed since January 1, 2013. This action is being taken at the user level due to the observation of visible particulates in some products.
**Impact:**
The presence of visible particulates in sterile compounds poses significant health risks, particularly if used in patient care environments. These particulates can lead to serious complications when injected or administered intravenously, including blockage of blood vessels, inflammation, or infection.
**Product Scope:**
The recall affects all sterile compound products produced and distributed by Pallimed Solutions since the start of the year. Healthcare providers, pharmacists, and patients are advised to cease use immediately and return any affected products to the dispensing pharmacy.
**Regulatory and Safety Advisory:**
Health professionals should monitor patients who have received these compounds for any adverse effects and report any incidents to the FDA’s MedWatch program. Pharmacists are encouraged to check their inventory and ensure no recalled products are available for dispensing.
**Action Required:**
1. Stop using the affected sterile compound products immediately.
2. Return products to the place of purchase.
3. Monitor and report any adverse effects to the FDA MedWatch program.
4. Stay informed about updates on this recall situation.
For further information, please visit